Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Charles A. Herzog, Eberhard Ritz, Richard Asinger et al.|Kidney International|2011Cited by 925
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial FibrillationCarl van Walraven, B S P Hellemons, Robert G. Hart et al.|JAMA|2002Cited by 721
Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial FibrillationMiguel Zabalgoitia, Robert G. Hart, Jonathan L. Halperin et al.|Journal of the American College of Cardiology|1998Cited by 554
Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: I. Reduced Flow Velocity in the Left Atrial Appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)Martin E. Goldman, Jonathan L. Halperin, Lesly A. Pearce et al.|Journal of the American Society of Echocardiography|1999Cited by 364
Aortic Plaque in Atrial FibrillationJoseph L. Blackshear, Jonathan L. Halperin, Lesly A. Pearce et al.|Stroke|1999Cited by 133